Promotion of epithelial regeneration

Details for Australian Patent Application No. 2006268091 (hide)

Owner Renovo Ltd

Inventors Laverty, Hugh; Ferguson, Mark; O'Kane, Sharon; Occleston, Nick

Agent Davies Collison Cave

Pub. Number AU-B-2006268091

PCT Pub. Number WO2007/007098

Priority 0514262.5 12.07.05 GB

Filing date 12 July 2006

Wipo publication date 18 January 2007

Acceptance publication date 2 September 2010

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61L 26/00 (2006.01) Chemical aspects of, or use of materials for, liquid bandages

A61L 27/54 (2006.01) Materials for prostheses or for coating prostheses

A61L 27/60 (2006.01) Materials for prostheses or for coating prostheses

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/007098 Priority application(s): WO2007/007098

2 September 2010 Application Accepted

  Published as AU-B-2006268091

2 December 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 18 Nov 2010. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

31 March 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 18 Nov 2010

31 March 2011 Standard Patent Sealed

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006268098-Use of 3,1IB-CIS-dihydrotetrabenazine for the treatment of symptoms of Huntington's disease

2006268088-Pharmaceutical compositions comprising a TGF-beta superfamily member